Faculty Disclosures
| Omar A. Khan, MD, PhD |
No disclosure on file
|
|
No disclosure on file
|
| Pramote Laoprasert, MD |
No disclosure on file
|
| Erik J. Kobylarz, MD, PhD |
No disclosure on file
|
| Susan P. Koh, MD |
No disclosure on file
|
| Gregory Krauss, MD |
Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch. |
| Cheryl Frye |
No disclosure on file
|
| Gregory A. Worrell, MD |
Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. |
| Jason Brandt, PhD |
No disclosure on file
|
| Andrew G. Herzog, MD, MSc, FAAN |
Dr. Herzog has nothing to disclose. |
| Meriem K. Bensalem Owen, MD, FAAN |
Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace. |
| Kevin E. Chapman, MD |
No disclosure on file
|
| Kalarickal Oommen, MD, FAAN |
No disclosure on file
|
| Anil Shetty, MBBS |
No disclosure on file
|
| Angus Wilfong, MD |
No disclosure on file
|
| Kenneth L. Marek, MD |
Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation. |
| Alexandra C. Boske, MD |
Dr. Boske has nothing to disclose. |
| Masanori Takeoka, MD |
No disclosure on file
|
| Michael H. Handler, MD, FACS, FAAP |
No disclosure on file
|
| Gregory D. Cascino, MD, FAAN |
Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. |
| Kelly G. Knupp, MD |
The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research. |
| Susan Shaw, MD |
No disclosure on file
|
| Kristen Park, MD |
The institution of Dr. Park has received research support from CURE GRIN. The institution of Dr. Park has received research support from GRIN2B Foundation. |
| Bruce A. Cree, MD, PhD, MAS, FAAN |
The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care. |
| Andrew M. White, MD |
No disclosure on file
|
| Martin E. Sanders, MD |
No disclosure on file
|
| W. C. LaFrance, Jr., MD, MPH, FAAN |
Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities. |
| David Z. Wang, DO, FAHA, FAAN |
Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome. |
| Daniel Curry, MD |
The institution of Dr. Curry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearpoint Neuro. The institution of Dr. Curry has received research support from PTC Therapeutics. The institution of Dr. Curry has received research support from Neurogene. The institution of Dr. Curry has received research support from Grace Scientific. |
| Christianne N. Heck, MD |
Dr. Heck has nothing to disclose. |